Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 54

Sort by

Sort Order Select

Journal Articles

Azacitidine monotherapy versus combination regimens as post-allogeneic transplantation maintenance in high-risk myeloid malignancies: A retrospective cohort Study

Ying Shen, Pengyu Zhang, Aili He, Jianli Wang, Jie Liu, Wanhong Zhao, Liufang Gu, Jin Wang, Bo Lei, Xueying Li, Yun Yang

Blood (2025) 146 (Supplement 1): 2499.

https://doi.org/10.1182/blood-2025-2499

Published: 2025

Journal Articles

Pan-leukemia 3D genomic profile reveals extreme long polycomb loop in subset of CEBPA mutated AMLs sensitive to EZH2 inhibition

Sean Moran, Miriam Zanovello, Zhong Fan, Chao Lu, Jie Liu, Xiaotian Zhang

Blood (2025) 146 (Supplement 1): 1447.

https://doi.org/10.1182/blood-2025-1447

Published: 2025

Journal Articles

Construction of mindfulness based cancer rehabilitation training program for malignant hematology patients based on the Liverpool mindfulness model

Rong Fu, Jie Liu, Rongrong Wang, Jianlan Ren, Wei Zhang

Blood (2025) 146 (Supplement 1): 6423.

https://doi.org/10.1182/blood-2025-6423

Published: 2025

Journal Articles

Venetoclax combined with three-day multi-frequency decitabine, vincristine and dexamethasone (VDVD) as induction treatment for patients with de novo acute leukaemias of ambiguous lineage

Xingli Zhao, Xiaohui SUO, Guanchen Bai, Yanliang Bai, Fang Zheng, Jie Liu, Ling Li, Yingchang Mi, Kaiqi Liu

Blood (2025) 146 (Supplement 1): 3451.

https://doi.org/10.1182/blood-2025-3451

Published: 2025

Journal Articles

Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) as induction treatment in newly diagnosed Acute Myeloid Leukemia with TP53-mutantion

Fang Zheng, Xiaohui SUO, Jie Liu, Liyun Zhao, Guanchen Bai, Xingli Zhao, Yanliang Bai, Dongmei Wang, Yingchang Mi, Kaiqi Liu

Blood (2025) 146 (Supplement 1): 3395.

https://doi.org/10.1182/blood-2025-3395

Published: 2025

Journal Articles

Rituximab, cyclophosphamide, mitoxantrone hydrochloride liposome, vincristine, and prednisone (R-CMOP) in elderly patients with newly diagnosed diffuse large B-cell lymphoma: A multicenter, prospective study

Xiaolian Wen, Lieyang Wang, Li Ma, Bing Xu, Yanping Ma, Jingrong Wang, Shaohua Wu, Jin Zhao, Zhiqiang Zhao, Yalan Wang, Jie Liu, Liping Su

Blood (2025) 146 (Supplement 1): 3697.

https://doi.org/10.1182/blood-2025-3697

Published: 2025

Journal Articles

Deciphering opsonized zymosan–induced phosphorylation of p47 phox and NADPH oxidase activation in human neutrophils

Jie Liu, Coralie Pintard, Nathalie Thieblemont, Pham My-Chan Dang, Jamel El-Benna

Blood (2025) 146 (13): 1601–1611.

https://doi.org/10.1182/blood.2024027018

Published: 2025

Includes: Supplemental data

Journal Articles

7-Day Venetoclax Combined with Intensive Chemotherapy As Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 2885.

https://doi.org/10.1182/blood-2024-198844

Published: 2024

Journal Articles

Symptom Burden and Health-Related Quality of Life in Patients with Aggressive Non-Hodgkin Lymphoma in China: A Cross-Sectional Study

Jiayue Jin, Simeng Ren, Wei Zhang, Ping Yang, Jingqi Yang, Hongkun Xu, Baojin Han, Wenzheng Zhang, Jie - Liu

Blood (2024) 144 (Supplement 1): 6437.

https://doi.org/10.1182/blood-2024-194707

Published: 2024

Journal Articles

Venetoclax Combined with Intensive Chemotherapy As an Induction Chemotherapy in Newly Diagnosed FLT3-ITD Positive AML

Blood (2024) 144 (Supplement 1): 1485.

https://doi.org/10.1182/blood-2024-203422

Published: 2024

Journal Articles

Predictive Modeling of Clonal Hematopoiesis across Diverse Cohorts

Armel L. Batchi-Bouyou, Duc Tran, Michael Raddatz, Teng Gao, Caitlyn Vlasschaert, Brian Sharber, Jie Liu, Giulia Petrone, Irenaeus C.C. Chan, J. Scott Beeler, Griffen Mustion, Sean M. Devlin, Alexander G. Bick, Kelly Bolton

Blood (2024) 144 (Supplement 1): 1285.

https://doi.org/10.1182/blood-2024-210900

Published: 2024

Journal Articles

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

Blood (2024) 144 (Supplement 1): 6925.

https://doi.org/10.1182/blood-2024-205155

Published: 2024

Journal Articles

Circulating Tumour DNA Measurements As an Early Prognostic Indicator for Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Pola-R-CHP Regimen

Xiaolian Wen, Liping Su, Tao Guan, Jie Liu, Xuliang Shen

Blood (2024) 144 (Supplement 1): 6186.

https://doi.org/10.1182/blood-2024-206716

Published: 2024

Journal Articles

Plasma Proteomic Signature Predicts Risk of Myeloid Neoplasm

J. Scott Beeler, Duc Tran, Jie Liu, Zilan Xin, Brian Wiley, Irenaeus C.C. Chan, Michael H. Kramer, Armel L. Batchi-Bouyou, Xiaoyu Zong, Matthew J. Walter, Sarantis Chlamydas, Francesca Ferraro, Stephen T. Oh, Ben Busby, Daniel C. Link, Yin Cao, Kelly L. Bolton

Blood (2023) 142 (Supplement 1): 940.

https://doi.org/10.1182/blood-2023-190857

Published: 2023

Journal Articles

Genetic Determinants of Clonal Hematopoiesis and Progression to Hematologic Malignancies in 479,117 Individuals

Jie Liu, Duc Tran, Irenaeus C.C. Chan, Brian Wiley, Caroline Watson, Armel L. Batchi-Bouyou, Xiaoyu Zong, Konrad H. Stopsack, Paul Pharoah, Li Ding, Jamie R Blundell, Yin Cao, Matthew J. Walter, Nilanjan Chatterjee, Kenneth Offit, Lucy Godley, Daniel C. Link, Zsofia Stadler, Kelly L. Bolton

Blood (2023) 142 (Supplement 1): 811.

https://doi.org/10.1182/blood-2023-182423

Published: 2023

Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial

Blood (2023) 142 (Supplement 1): 969.

https://doi.org/10.1182/blood-2023-179205

Published: 2023

Journal Articles

Arcch: Improving the Performance of Clonal Hematopoiesis Variant Calling and Interpretation Using a Consensus Based Approach

Evelyn L Schmidt, Irenaeus C.C. Chan, Alex Panchot, Brian Wiley, Jie Liu, Lea Moukarzel, Yiwen Zhang, Daniel C. Link, Konrad Stopsack, Kelly L Bolton

Blood (2022) 140 (Supplement 1): 5762–5763.

https://doi.org/10.1182/blood-2022-170221

Published: 2022

Journal Articles

Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34 + Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent β-Thalassemia

Blood (2022) 140 (Supplement 1): 10652–10653.

https://doi.org/10.1182/blood-2022-166365

Published: 2022

Journal Articles

Dissecting the Knowns for the Unknowns: Refining the Classification of Genomic Variations in Hematological Diseases By the Clingen Hematological Cancer Taskforce (HCT)

Blood (2022) 140 (Supplement 1): 11810–11811.

https://doi.org/10.1182/blood-2022-170989

Published: 2022

Journal Articles

Expert Curation of Somatic FLT3 Variants By the Clingen Somatic Hematologic Cancer Taskforce (ClinGen HCT)

Blood (2021) 138 (Supplement 1): 4387.

https://doi.org/10.1182/blood-2021-153546

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Azacitidine monotherapy versus combination regimens as post-allogeneic transplantation maintenance in high-risk myeloid malignancies: A retrospective cohort Study

Pan-leukemia 3D genomic profile reveals extreme long polycomb loop in subset of CEBPA mutated AMLs sensitive to EZH2 inhibition

Construction of mindfulness based cancer rehabilitation training program for malignant hematology patients based on the Liverpool mindfulness model

Venetoclax combined with three-day multi-frequency decitabine, vincristine and dexamethasone (VDVD) as induction treatment for patients with de novo acute leukaemias of ambiguous lineage

Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) as induction treatment in newly diagnosed Acute Myeloid Leukemia with TP53-mutantion

Rituximab, cyclophosphamide, mitoxantrone hydrochloride liposome, vincristine, and prednisone (R-CMOP) in elderly patients with newly diagnosed diffuse large B-cell lymphoma: A multicenter, prospective study

Deciphering opsonized zymosan–induced phosphorylation of p47 phox and NADPH oxidase activation in human neutrophils

7-Day Venetoclax Combined with Intensive Chemotherapy As Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia

Symptom Burden and Health-Related Quality of Life in Patients with Aggressive Non-Hodgkin Lymphoma in China: A Cross-Sectional Study

Venetoclax Combined with Intensive Chemotherapy As an Induction Chemotherapy in Newly Diagnosed FLT3-ITD Positive AML

Predictive Modeling of Clonal Hematopoiesis across Diverse Cohorts

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

Circulating Tumour DNA Measurements As an Early Prognostic Indicator for Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Pola-R-CHP Regimen

Plasma Proteomic Signature Predicts Risk of Myeloid Neoplasm

Genetic Determinants of Clonal Hematopoiesis and Progression to Hematologic Malignancies in 479,117 Individuals

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial

Arcch: Improving the Performance of Clonal Hematopoiesis Variant Calling and Interpretation Using a Consensus Based Approach

Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34 + Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent β-Thalassemia

Dissecting the Knowns for the Unknowns: Refining the Classification of Genomic Variations in Hematological Diseases By the Clingen Hematological Cancer Taskforce (HCT)

Expert Curation of Somatic FLT3 Variants By the Clingen Somatic Hematologic Cancer Taskforce (ClinGen HCT)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only